Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Consolidated Net Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,885 Cr₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr

What is the latest Consolidated Net Profit of NATCO PHARMA ?

The latest Consolidated Net Profit ratio of NATCO PHARMA is ₹1,885 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,885 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹441 Cr

How is Consolidated Net Profit of NATCO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,885 Cr
35.81
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.44
Mar2021 ₹441 Cr -

Compare Consolidated Net Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,173.6 Cr 4.3% 6% -34.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,764.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹170,489.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,442.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,088.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,162.0 Cr 2.7% 0.4% 3.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.3%

6%

-34.9%

SENSEX

0.9%

0.8%

7.1%


You may also like the below Video Courses